A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Parkinson's DiseasePrimary ParkinsonismLewy Body Parkinson's Disease
Interventions
DRUG

18F-AV-133

222 MBq (6 mCi)

Trial Locations (15)

2109

Research Site, Sydney

19107

Research Site, Philadelphia

21287

Research Site, Baltimore

44195

Research Site, Cleveland

63110

Research Site, St Louis

66160

Research Site, Kansas City

71103

Research Site, Shreveport

75390

Research Site, Dallas

77030

Research Site, Houston

85259

Research Site, Scottsdale

85351

Research Site, Sun City

89106

Research Site, Las Vegas

06510

Research Site, New Haven

02114

Research Site, Boston

02906

Research Site, Providence

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY